Abiomed CE marks portable circulatory support system:
This article was originally published in Clinica
Executive Summary
Abiomed has CE marked its portable circulatory support driver for sale in Europe. The portable driver is designed to support Danvers, Massachusetts-based Abiomed's AB5000 ventricular assist device (VAD). It is lightweight, quiet and reliable, and is designed to improve patient care while lowering costs. The AB5000 portable driver provides a greater degree of mobility and improves the quality of life of patients during VAD use to aid myocardial recovery. The AB5000 VAD is already CE-marked in Europe and has supported patients for up to 312 days. Outside of the US, the AB5000 is used as a bridge-to-recovery and bridge-to-transplant (BTT) device, and the portable driver is expected to greatly enhance the company's BTT market opportunity. The circulatory support driver has not yet been approved in the US.